Numeta Neo, Emulsion zur Infusion
7680613360024
CH-61336
Emulsion
Associated product:
NUMETA NEO émuls perf 10 sach 300 ml
1 / 3
google
Article details
- Package size
- 10 x 300
- Selling units
- 10
- Measure
- ml
- Galenic form
- Emulsion
- Galenic group
- Salben
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
III
|
- | Substance | Wirkstoff (Principe actif) |
|
II
|
0.75 G | Substance | Wirkstoff (Principe actif) |
|
12C
|
5.9 GL | Substance | Wirkstoff (Principe actif) |
|
123C
|
4.7 GL | Substance | Wirkstoff (Principe actif) |
|
I
|
40.0 G | Substance | Wirkstoff (Principe actif) |
|
12C
|
39.0 GL | Substance | Wirkstoff (Principe actif) |
|
I
|
44.0 G | Substance | WIZUS |
|
III
|
7.5 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
31.0 GL | Substance | Wirkstoff (Principe actif) |
|
II
|
0.78 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
133.0 GL | Substance | Wirkstoff (Principe actif) |
|
II
|
0.56 G | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
12C
|
167.0 GL | Substance | Wirkstoff (Principe actif) |
|
123C
|
25.0 GL | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
II
|
0.18 G | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | HNIDK |
|
12C
|
27.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
22.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
II
|
0.93 G | Substance | Wirkstoff (Principe actif) |
|
12C
|
26.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
12C
|
2.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
21.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
II
|
0.37 G | Substance | Wirkstoff (Principe actif) |
|
II
|
0.35 G | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
12C
|
16.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
1.6 MMOLL | Substance | Wirkstoff (Principe actif) |
|
12C
|
13.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
II
|
0.62 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
13.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
13.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
II
|
0.93 G | Substance | Wirkstoff (Principe actif) |
|
12C
|
30.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
12C
|
13.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
123C
|
24.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
II
|
1.03 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
11.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
12C
|
39.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
II
|
1.15 G | Substance | WIZUS |
|
II
|
0.22 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
31.0 MMOLL | Substance | Wirkstoff (Principe actif) |
|
II
|
0.23 G | Substance | Wirkstoff (Principe actif) |
|
II
|
0.3 G | Substance | WIZUS |
|
II
|
0.39 G | Substance | Wirkstoff (Principe actif) |
|
II
|
0.28 G | Substance | Wirkstoff (Principe actif) |
|
II
|
0.37 G | Substance | Wirkstoff (Principe actif) |
|
II
|
0.06 G | Substance | Wirkstoff (Principe actif) |
|
II
|
0.35 G | Substance | Wirkstoff (Principe actif) |
|
II
|
0.19 G | Substance | Wirkstoff (Principe actif) |
|
II
|
0.07 G | Substance | Wirkstoff (Principe actif) |
|
II
|
0.71 G | Substance | Wirkstoff (Principe actif) |
|
II
|
0.61 G | Substance | Wirkstoff (Principe actif) |
|
II
|
0.41 G | Substance | Wirkstoff (Principe actif) |
|
II
|
0.55 G | Substance | WIZUS |
|
II
|
0.07 G | Substance | Wirkstoff (Principe actif) |
|
II
|
0.1 G | Substance | WIZUS |
|
II
|
0.69 G | Substance | Wirkstoff (Principe actif) |
|
II
|
0.98 G | Substance | WIZUS |
|
II
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1004.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2023
Authorization holder
Baxter AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 61336
- Drug name
- Numeta Neo, Emulsion zur Infusion
- Galenic form
- EMUI
- ATC Code
- B05BA10
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 28/10/2011
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.01.2.
- Domain
- Human medicine
Package details
- Description (FR)
- NUMETA NEO émuls perf 10 sach 300 ml
- Description (DE)
- NUMETA NEO Inf Emuls 10 Btl 300 ml
- Market launch
- 15/06/2016
- Narcotic (BTM)
- No
Other package sizes (1)
NUMETA NEO sol perf 10 sach 300 ml
10 x 300 ML
GTIN: 7680613360017